(2S,3R)-2-(3,4,5-Trihydroxyphenyl)chromane-3,5,7-triol

Catalog No.: 
ACWXPV329
CAS No.: 
3371-27-5
Molecular Formula: 
C15H14O7
Molecular Weight: 
306.27
(2S,3R)-2-(3,4,5-Trihydroxyphenyl)chromane-3,5,7-triol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$103.00In stockInquiry
50mg98%$185.00InquiryInquiry
100mg98%$295.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,3R)-2-(3,4,5-Trihydroxyphenyl)chromane-3,5,7-triol
IUPAC Name(2S,3R)-2-(3,4,5-trihydroxyphenyl)chromane-3,5,7-triol
MDL No.MFCD01632616
Molecular FormulaC15H14O7
Molecular Weight306.27
SMILESO[C@@H]1CC2=C(O)C=C(O)C=C2O[C@H]1C1=CC(O)=C(O)C(O)=C1
InChI KeyXMOCLSLCDHWDHP-DOMZBBRYSA-N
SynonymGallocatechin (GC) | (-)-Gallocatechin | (-)-Gallocatechin, >=98% (HPLC) | (2S,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol | Q27139455 | (2S,3R)-2-(3,4,5-trihydroxyphenyl)chromane-3,5,7-triol | (2S,3R)-2-(3,4,5-trihydroxyphenyl
CAS No.3371-27-5
PubChem CID9882981

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWXPV329 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWXPV329 route product structure diagram
    ACWXPV3293371-27-5In Stock
Inquiry

2. ACWXPV329 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWXPV329 route product structure diagram
    ACWXPV3293371-27-5In Stock
Inquiry

3. ACWXPV329 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWXPV329 route product structure diagram
    ACWXPV3293371-27-5In Stock
Inquiry

Comments (0)